S&P 5007,765.36▼0.5% Nasdaq27,193.34▼1.2% Dow51,231.64▲0.1% Russell 2K2,794.13▲0.0% 10-Yr5.23%−5bp VIX15.41+0.33 WTI$91.10▲3.2% Gold$4,157.80▲0.4% EUR/USD1.122▼0.3% BTC$84,464▲1.8% Nikkei70,036▼0.9%
At close · Thu, Oct 8, 2026
Daily Market Updates.

ETFs & Funds

Home›ETFs & Funds›Equity Funds›Moderna is about to release the trial results for its…

Moderna is about to release the trial results for its cancer vaccine. A lot is riding on this data.

Reported · Written up by our desk · Equity Funds

Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.

← Newer storyBooking.com under investigation by EU regulators over fake listings a…

More like this

ETFs & FundsWhy investors should be skeptical of a potential Tesla-SpaceX merger
ETFs & FundsOil is now flowing out of the Persian Gulf like before the Iran war. Why prices may still not come down anytime soon.
ETFs & Funds7 healthcare stocks that stand out as investors pay up for the sector
ETFs & FundsWhy Consider Actively Managed Investment-Grade ETFs?
ETFs & FundsSpaceX’s massive AI targets will test the limits of reality

Sources

MarketWatchModerna is about to release the trial results for its cancer vaccine. A lot is riding on this data.
MarketWatchModerna is about to release the trial results for its cancer vaccine. A lot is riding on this data.

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.